B. Riley Wealth Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$411 Buy
26,925
+15,742
+141% +$283K ﹤0.01% 457
2022
Q1
$236K Buy
11,183
+2,567
+30% +$55.3K 0.02% 514
2021
Q4
$204K Buy
+8,616
New +$185K 0.01% 581
2020
Q4
Sell
-12,188
Closed -$215K 435
2020
Q3
$215K Buy
+12,188
New +$227K 0.03% 349
2015
Q3
Sell
-5,921
Closed -$77K 527
2015
Q2
$77K Buy
5,921
+1,020
+21% +$14.2K 0.06% 324
2015
Q1
$72K Sell
4,901
-1,479
-23% -$22K 0.05% 350
2014
Q4
$87K Buy
6,380
+2,000
+46% +$26.8K 0.07% 298
2014
Q3
$53K Buy
4,380
+1,428
+48% +$19K 0.04% 398
2014
Q2
$39K Buy
2,952
+2,400
+435% +$31.9K 0.03% 515
2014
Q1
$7K Buy
+552
New +$7.09K 0.01% 839

Other funds holding MPT

B. Riley Wealth Management's MPT Position: Q2 2022 in Review

B. Riley Wealth Management increased its Medical Properties Trust (MPT) stake by 141% in Q2 2022, buying an estimated $283K and bringing the position to 26,925 shares worth $411. The position accounts for ﹤0.01% of the portfolio, ranked #457.

B. Riley Wealth Management first reported a position in MPT in Q1 2014 and has held it in 10 quarters since. The position peaked at $236K in Q1 2022. 605 funds tracked by Wall St. Rank hold MPT as of Q2 2022.

  • B. Riley Wealth Management held 26,925 shares of Medical Properties Trust worth $411 as of Q2 2022.
  • B. Riley Wealth Management bought 15,742 Medical Properties Trust shares in Q2 2022, an estimated $283K.
  • Medical Properties Trust made up ﹤0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #457 holding.
  • B. Riley Wealth Management first reported a position in Medical Properties Trust in Q1 2014 and has held it in 10 quarters since.
  • B. Riley Wealth Management's Medical Properties Trust position peaked at $236K in Q1 2022.
  • 605 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.